CBDQ, also known as CBD-HQ, was first discovered by Raphael Mechoulam at the Hebrew University in Jerusalem and is a derivation of the natural aging process of CBD. The Q stands for “Quinone”, which is produced naturally during the process of polyphenol oxidization in plant cells. Chemically, quinones are a class of organic compounds which are derived from aromatic compounds through double bond conversions. A similar, household example of this process happens when apples turn brown. Via contact with oxygen, the apple’s polyphenols are oxidized into quinones, which give the brown appearance over a short period of time. This process, superimposed on an apple, happens quickly. Conversely, the quinones in CBD require significantly longer to mature, sometimes taking between 10 and 15 years to complete the same process.

Under controlled conditions, that process can be expedited through pure oxygen infusions and strict climate regulations. This lab-based procedure shortens that 10-15 year mark down to approximately three weeks.

If stored at room temperature and protected from UV light, the shelf life of this isolate is 6-12 months. Its slightly floral aroma sets this isolate apart, but that’s hardly the extent of its benefits. CBDQ is unique in its ability to act as a Topoisomerade Type II Inhibitor, contributing to its perception as a cancer cell reducer. Although more research needs to be done on the physiological impact of CBD remedies like CBDQ on cancer cells, the future looks bright for CBD as pain relief. Another study has shown a link between CBD and a slowed growth, and subsequent death, of some cancer cells. Animal studies have also shown that taking CBD reduces the spread of cancer cells; these trials are in the early stages of human implementation.

CBDQ is currently the only isolate sold by Colorado Chromatography that has been shown to target cancer cells specifically and is fantastic in most formulations to get a tasteless, non-psychoactive addition to capsules, tinctures, balms, vapes, and more. One kilogram of CBDQ can produce 1,960 units of e-liquid or tinctures, 1,633 capsules, or 4,900 units for topical uses.

With a purity level of 98 to 99 percent, Colorado Chromatography studies CBDQ and other naturally-occurring minor cannabinoids and are pioneering quality and purity standards.